Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics 2024, 16, 913

Key Points

• The aim is to explore the enhanced effectiveness of ω-3 polyunsaturated fatty acids combined with nanotechnology in delivering therapy for breast cancer.
• Correction of previous text errors related to the study design and methodology.
• Review of liposomal formulation techniques for drug delivery.
• Analysis of ω-3 polyunsaturated fatty acid combinations with PTX (Paclitaxel) for therapy.
• Discussion on the implications of nanotechnology in drug delivery systems.
• Improvements in drug delivery efficiency were noted with the use of liposomal formulations.
• Increased therapeutic effectiveness in breast cancer models was observed with ω-3 fatty acid therapy.
• A corrected understanding of mechanisms underlying enhanced treatment effects was established.